Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Tom Powles
Oct 25, 2023, 17:27 |
Insight
Tom Powles: TAR-210 releases Erdafitinib slowly into the bladder by a novel release system
Tom Powles, Director of Barts Cancer Centre, shared on Twitter: ''Something NEW. TAR-210 releases Erdafitinib…
Oct 23, 2023, 15:26 |
Insight
Tom Powles: Enfortumab vedotin and Pembrolizumab improving PFS and OS by 55% and 53% respectively compared to platinum based chemo in 1st line UC (+avelumab in 30%)
Tom Powles, Director of Barts Cancer Centre, shared on Twitter: "Enfortumab vedotin and Pembrolizumab improving…
Oct 21, 2023, 14:04 |
Drugs
Tom Powles: Renal cancer highlights ESMO23
Tom Powles Director of Barts Cancer Centre, shared a post on LinkedIn, saying: "Renal cancer…
Jul 14, 2024, 05:39 |
Blog
Thomas Powles: An intratumoral micro-device releases small amounts of drugs locally to assess efficacy
Thomas Powles posted on X: "An intratumoral micro-device releases small amounts of drugs locally to…
Feb 1, 2024, 15:42 |
Opinion
Thomas Powles: Enfortumab Vedotin and Pembrolizumab shows broad spectrum of activity for Regional Recurrence, Progression-free survival and Overall Survival in all subgroups
Jan 31, 2024, 15:42 |
Blog
Thomas Powles: We need better biomarkers in Urothelial Carcinoma
Thomas Powles, Director of Barts Cancer Centre, shared a post on X/Twitter: "Microsatellite instability (MSIH)…
Sep 17, 2024, 10:06 |
Insight
Sumanta K. Pal: Important analysis of SWOG 1500 published just ahead of ESMO24
Sumanta K. Pal shared a post on X: "Huge congrats to Pedro C Barata, who drove…
Sep 16, 2024, 16:31 |
Societies
40 Posts Not To Miss From ESMO24 Day 3
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at the…
Sep 16, 2024, 16:18 |
Societies
Key Findings from the NIAGARA Trial at ESMO 2024
The results of the NIAGARA trial were recently presented at ESMO 2024. The NIAGARA trial,…
Sep 15, 2024, 16:26 |
Societies
43 Posts Not To Miss From ESMO24 Day 2
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at the…
3
4
5
6
7
All:
91
Posts:
41 - 50
43 Posts Not To Miss From ESMO24 Day 2
45 Posts not to miss from ESMO24 Day 1
OncoDaily Announces Strategic Partnership with the Asian Fund for Cancer Research Limited (AFCR)
Peyo the Therapy Horse: Comforting Terminally Ill Patients Through Horse Therapy.
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube